Literature DB >> 8200342

Solid-phase synthesis, conformational analysis and in vitro cleavage of synthetic human synaptobrevin II 1-93 by tetanus toxin L chain.

F Cornille1, N Goudreau, D Ficheux, H Niemann, B P Roques.   

Abstract

A 93-residue peptide corresponding to the cytosolic domain of a human vesicle associated membrane protein (VAMP or synaptobrevin) has been prepared by solid-phase peptide synthesis in order to investigate the proteolytic activity of the tetanus toxin light chain (TeTx L chain). This protein has been recently reported to inactivate the neuronal rat synaptobrevin II by proteolysis. We show in this study that the synthetic human synaptobrevin II 1-93 (Syb II 1-93) as well as an N-terminus-shortened 69-residue peptide (Syb II 25-93) were cleaved selectively at the Gln76-Phe77 peptide bond by TeTx L chain while shorter peptides were not. A Michaelis constant Km = 192 +/- 2 microM and a catalytic constant kcat = 0.5 min-1 were found for the 93-residue peptide. A neutral optimum pH for the cleavage rate, an inhibition by preincubation of the toxin with well known nonspecific inhibitors of metallopeptidases as well as a zinc-dependent enzyme activity suggest that TeTx belongs to the zinc endopeptidase family. Moreover an activation by reducing agents and an inhibition by cysteine-modifying chemical reagents indicate a critical thiol dependency. Among several specific inhibitors of zinc endopeptidases tested, none could inhibit TeTx L chain even at high concentration. Structural studies by 600-MHz 1H-NMR showed that in water or dimethylsulfoxide the peptide Syb II 1-93 and shorter fragments did not present well defined conformations. Nevertheless protein-protein interactions have been shown for the peptides Syb II 1-93 and 25-93 but not for Syb II 51-93, a fragment not cleaved by TeTx L chain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200342     DOI: 10.1111/j.1432-1033.1994.tb18855.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Identification and characterization of an 18-kilodalton, VAMP-like protein in suspension-cultured carrot cells.

Authors:  M Gasparian; M Pusterla; B Baldan; P M Downey; O Rossetto; P P de Laureto; F Filippini; M Terzi; F Lo Schiavo
Journal:  Plant Physiol       Date:  2000-01       Impact factor: 8.340

2.  Effect of mutations in vesicle-associated membrane protein (VAMP) on the assembly of multimeric protein complexes.

Authors:  J C Hao; N Salem; X R Peng; R B Kelly; M K Bennett
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

3.  Proteolysis of synthetic peptides by type A botulinum neurotoxin.

Authors:  J J Schmidt; K A Bostian
Journal:  J Protein Chem       Date:  1995-11

4.  Peptide phage display library as source for inhibitors of clostridial neurotoxins.

Authors:  A G Zdanovsky; N V Karassina; D Simpson; M V Zdanovskaia
Journal:  J Protein Chem       Date:  2001-01

5.  Total direct chemical synthesis and biological activities of human group IIA secretory phospholipase A2.

Authors:  Chang-Zhi Dong; Anthony Romieu; Carine M Mounier; Françoise Heymans; Bernard P Roques; Jean-Jacques Godfroid
Journal:  Biochem J       Date:  2002-07-15       Impact factor: 3.857

Review 6.  Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.

Authors:  R Pellizzari; O Rossetto; G Schiavo; C Montecucco
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

7.  Metal substitution of tetanus neurotoxin.

Authors:  F Tonello; G Schiavo; C Montecucco
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

Review 8.  The zinc-dependent protease activity of the botulinum neurotoxins.

Authors:  Frank J Lebeda; Regina Z Cer; Uma Mudunuri; Robert Stephens; Bal Ram Singh; Michael Adler
Journal:  Toxins (Basel)       Date:  2010-05-07       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.